Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Blood ; 131(26): 2978-2986, 2018 06 28.
Artículo en Inglés | MEDLINE | ID: mdl-29674425

RESUMEN

Respiratory viral infections are frequent in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT) and can potentially progress to lower respiratory tract infection (LRTI). The intestinal microbiota contributes to resistance against viral and bacterial pathogens in the lung. However, whether intestinal microbiota composition and associated changes in microbe-derived metabolites contribute to the risk of LRTI following upper respiratory tract viral infection remains unexplored in the setting of allo-HCT. Fecal samples from 360 allo-HCT patients were collected at the time of stem cell engraftment and subjected to deep, 16S ribosomal RNA gene sequencing to determine microbiota composition, and short-chain fatty acid levels were determined in a nested subset of fecal samples. The development of respiratory viral infections and LRTI was determined for 180 days following allo-HCT. Clinical and microbiota risk factors for LRTI were subsequently evaluated using survival analysis. Respiratory viral infection occurred in 149 (41.4%) patients. Of those, 47 (31.5%) developed LRTI. Patients with higher abundances of butyrate-producing bacteria were fivefold less likely to develop viral LRTI, independent of other factors (adjusted hazard ratio = 0.22, 95% confidence interval 0.04-0.69). Higher representation of butyrate-producing bacteria in the fecal microbiota is associated with increased resistance against respiratory viral infection with LRTI in allo-HCT patients.


Asunto(s)
Bacterias/metabolismo , Butiratos/metabolismo , Microbioma Gastrointestinal , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Infecciones del Sistema Respiratorio/etiología , Infecciones del Sistema Respiratorio/microbiología , Virosis/etiología , Virosis/microbiología , Adulto , Heces/microbiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores Protectores , Infecciones del Sistema Respiratorio/metabolismo , Trasplante Homólogo/efectos adversos , Virosis/metabolismo
2.
Cardiol Young ; 26(3): 506-15, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25917060

RESUMEN

BACKGROUND: Cardiopulmonary bypass is associated with systemic inflammatory response. Steroids suppress this response, although the therapeutic evidence remains controversial. We hypothesised that intravenous steroids in children undergoing open-heart surgery would decrease inflammation leading to better early post-operative outcomes. We conducted a randomised controlled trial to evaluate the trends in the levels of immunomodulators and their effects on clinical parameters. OBJECTIVE: To assess the effects of intravenous steroids on early post-operative inflammatory markers and clinical parameters in children undergoing open-heart surgery. MATERIALS AND METHODS: A randomised controlled trial involving 152 patients, from one month up to 18 years of age, who underwent open-heart surgery for congenital heart disease from April 2010-2012 was carried out. Patients were randomised and administered either three scheduled intravenous pulse doses of dexamethasone (1 mg/kg) or placebo. Blood samples were drawn at four time intervals and serum levels of inflammatory cytokines - Interleukin-6, 8, 10, 18, and tumour necrosis factor-alpha - were measured. Clinical parameters were also assessed. RESULTS: Blood cytokine levels were compared between the dexamethasone (n=65) and placebo (n=64) groups. Interleukin-6 levels were lower at 6 and 24 hours post-operatively (p<0.001), and Interleukin-10 levels were higher 6 hours post-operatively (p<0.001) in the steroid group. Interleukin-8, 18, and tumour necrosis factor-alpha levels did not differ between the groups at any time intervals. The clinical parameters were similar in both the groups. CONCLUSION: Dexamethasone caused quantitative suppression of Interleukin-6 and increased Interleukin-10 activation, contributing to reduced immunopathology, but it did not translate into clinical benefit in the short term.


Asunto(s)
Puente Cardiopulmonar/efectos adversos , Citocinas/sangre , Dexametasona/administración & dosificación , Cardiopatías Congénitas/terapia , Inflamación/sangre , Factor de Necrosis Tumoral alfa/sangre , Administración Intravenosa , Adolescente , Biomarcadores/sangre , Niño , Preescolar , Método Doble Ciego , Femenino , Cardiopatías Congénitas/sangre , Humanos , Lactante , Inflamación/prevención & control , Masculino , Pakistán
3.
Cleve Clin J Med ; 2021 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-33687984

RESUMEN

An effective vaccine is considered the best method to achieve herd immunity. As of February 2021, 12 vaccines were in late-stage clinical trials worldwide, with many more in development. Of those, 8 have received emergency use authorization from at least one country's governing body. These vaccines use various platforms to deliver the vaccines, each with pros and cons. Published data show these vaccines are effective in preventing the severe symptoms associated with COVID-19 in adults with few side effects, but challenges remain with storage and delivery and treating virus variants.

4.
Cleve Clin J Med ; 87(11): 659-663, 2020 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-32393593

RESUMEN

In COVID-19, respiratory infection with SARS-CoV-2 plus another virus (viral co-infection) or with SARS-CoV-2 plus a bacterial pathogen (combined viral and bacterial pneumonia) has been described. Secondary bacterial pneumonia can follow the initial phase of viral respiratory infection or occur during the recovery phase. No obvious pattern or guidelines exist for viral co-infection, combined viral and bacterial pneumonia, or secondary bacterial pneumonia in COVID-19. Based on existing clinical data and experience with similar viruses such as influenza and SARS-CoV, the management approach in COVID-19 should, ideally, take into consideration the overall presentation and the trajectory of illness.


Asunto(s)
Antibacterianos/administración & dosificación , Coinfección , Infecciones por Coronavirus , Pandemias , Manejo de Atención al Paciente/métodos , Neumonía Bacteriana , Neumonía Viral , Virosis , Bacterias/clasificación , Bacterias/aislamiento & purificación , COVID-19 , Prueba de COVID-19 , Técnicas de Laboratorio Clínico/métodos , Coinfección/diagnóstico , Coinfección/etiología , Coinfección/terapia , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/terapia , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/terapia , Infección Hospitalaria/epidemiología , Infección Hospitalaria/terapia , Diagnóstico Diferencial , Humanos , Neumonía Bacteriana/epidemiología , Neumonía Bacteriana/etiología , Neumonía Bacteriana/terapia , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Neumonía Viral/terapia , Virosis/epidemiología , Virosis/terapia
5.
J Pak Med Assoc ; 59(7): 426-9, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19579726

RESUMEN

OBJECTIVE: To determine the outcomes of primary percutaneous coronary intervention (PCI) in a tertiary care cardiac centre. METHODS: Medical records of 104 consecutive patients presented in our hospital between January 2006 to December 2007 with acute ST elevation myocardial infarction (STEMI) and treated with primary PCI as a mode of reperfusion were reviewed. The primary end point was in hospital mortality and secondary end points were 30 day mortality, myocardial infarction, recurrent angina and congestive cardiac failure, from discharge to one month follow up. RESULTS: The procedural success was 97%. Six (5.8%) patients died during hospital stay including one on table death. Out of six patients who died, five (83.3%) had cardiogenic shock. No mortality was observed in the 30 days follow up from discharge while other complications like myocardial infarction, recurrent angina and congestive cardiac failure were 1%, 1% and 5% respectively. CONCLUSIONS: Our findings suggest that favourable outcomes, matching the international data can be achieved in our patients with primary PCI in the management of life threatening illness like STEMI despite all the limitations. Primary PCI as a preferred method of reperfusion strategy fieeds to be practiced more often in our part of the world.


Asunto(s)
Angioplastia Coronaria con Balón , Atención Terciaria de Salud , Mortalidad Hospitalaria , Humanos , Infarto del Miocardio , Intervención Coronaria Percutánea
6.
Chest ; 153(5): 1160-1168, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29391140

RESUMEN

BACKGROUND: Patients admitted to the medical ICU (MICU) are often subjected to multiple radiologic studies. We hypothesized that some endure radiation dose exposure (cumulative effective dose [CED]) in excess of annual US federal occupational health standard limits (CED ≥ 50 mSv) and 5-year cumulative limit (CED ≥ 100 mSv). We also evaluated the correlation of CED with Acute Physiology and Chronic Health Evaluation (APACHE) III score and other clinical variables. METHODS: Retrospective observational study conducted in an academic medical center involving all adult admissions (N = 4,155) to the MICU between January 2013 and December 2013. Radiation doses from ionizing radiologic studies were calculated from reference values to determine the CED. RESULTS: Three percent of admissions (n = 131) accrued CED ≥ 50 mSv (1% [n = 47] accrued CED ≥ 100 mSv). The median CED was 0.72 mSv (interquartile range, 0.02-5.23 mSv), with a range of 0.00 to 323 mSv. Higher APACHE III scores (P = .003), longer length of MICU stay (P < .0001), sepsis (P = .03), and gastrointestinal disorders and bleeding (P < .0001) predicted higher CED in a multivariable linear regression model. Patients with gastrointestinal bleeding and disorders had an odds ratio of 21.05 (95% CI, 13.54-32.72; P < .0001) and 6.94 (95% CI, 3.88-12.38; P < .0001), respectively, of accruing CED ≥ 50 mSv in a multivariable logistic regression model. CT scan and interventional radiology accounted for 49% and 38% of the total CED, respectively. CONCLUSIONS: Patients in the MICU are exposed to radiation doses that can be substantial, exceeding federal annual occupational limits, and in a select subset, are > 100 mSv. Efforts to justify, restrict, and optimize the use of radiologic resources when feasible are warranted.


Asunto(s)
Unidades de Cuidados Intensivos , Exposición a la Radiación , APACHE , Adulto , Anciano , Femenino , Humanos , Tiempo de Internación , Modelos Logísticos , Masculino , Persona de Mediana Edad , Dosis de Radiación , Radiografía , Estudios Retrospectivos , Factores de Riesgo
7.
J Med Case Rep ; 11(1): 93, 2017 Apr 06.
Artículo en Inglés | MEDLINE | ID: mdl-28381237

RESUMEN

BACKGROUND: One of the rare presentations of active pulmonary or even extrapulmonary tuberculosis is polyarthropathy which is the involvement of multiple large and small joints in the body; a reactive constellation known as Poncet's disease. This may sometimes be the sole manifestation of the disease before more obvious features develop. The pain experienced during polyarthritis can be crippling thereby limiting the mobility and activities of patients. Polyarthritis as a symptom of active tuberculosis can be easily misinterpreted for more common causes of polyarthritis such as rheumatological diseases that present similarly. CASE PRESENTATION: We describe the case of a 25-year-old Asian woman and a 45-year-old Asian man who presented with active tuberculosis where polyarthralgia was the first and only symptom for many months followed by pulmonary and pleural manifestations. Both patients showed dramatic improvement with anti-tuberculous therapy. The total duration of therapy was 6 months. CONCLUSIONS: Based on our observations, we propose that tuberculosis be included among the differentials for patients with unusual presentation of joint pains, especially in endemic regions and/or susceptible populations.


Asunto(s)
Antituberculosos/uso terapéutico , Artritis Reactiva/diagnóstico , Tuberculosis/tratamiento farmacológico , Adulto , Artritis Reactiva/tratamiento farmacológico , Artritis Reactiva/microbiología , Pueblo Asiatico , Femenino , Humanos , Masculino , Mycobacterium tuberculosis/aislamiento & purificación , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Prueba de Tuberculina , Tuberculosis/complicaciones , Tuberculosis/fisiopatología
8.
Trop Doct ; 42(2): 94-6, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22328602

RESUMEN

Our study compares the risk factors, clinical presentations and outcomes of pulmonary infections caused by Nocardia asteroides and non-asteroides species. We performed a retrospective cohort study comparing pulmonary infections by both species in patients presenting to a tertiary care hospital in Karachi, Pakistan. Forty-one patients were identified with pulmonary nocardiosis, with 58.5% belonging to the N. asteroids complex. The most common clinical findings were fever and a cough for both groups, with lobar infiltrates being the most common finding on chest radiographs. In vitro testing showed a sensitivity of all species to trimethoprim-sulfamethoxazole (TMP-SMZ), aminoglycosides, ceftriaxone and imipenem. The majority of the patients were treated with TMP-SMZ in combination with other drugs. The results of our study suggest that there is no significant difference in the risk factors, presentations and outcomes of pulmonary infections by N. asteroides and non-asteroides species. Immunocompromised patients are more likely to have unfavorable outcomes.


Asunto(s)
Enfermedades Pulmonares/fisiopatología , Nocardiosis/fisiopatología , Nocardia asteroides/patogenicidad , Nocardia/patogenicidad , Adulto , Anciano , Antibacterianos/uso terapéutico , Estudios de Cohortes , Femenino , Hospitales Universitarios/estadística & datos numéricos , Humanos , Huésped Inmunocomprometido , Enfermedades Pulmonares/epidemiología , Enfermedades Pulmonares/microbiología , Enfermedades Pulmonares/patología , Masculino , Persona de Mediana Edad , Nocardia/clasificación , Nocardiosis/epidemiología , Nocardiosis/microbiología , Nocardiosis/patología , Pakistán/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico
9.
J Ophthalmic Inflamm Infect ; 2(2): 65-73, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22167465

RESUMEN

PURPOSE: This study aims to investigate the relationship between macular sensitivity and thickness in eyes with uveitic macular edema (UME). DESIGN: This study is a prospective observational case series. METHODS: The setting for this study was clinical practice. The study included 59 (28 with UME, 31 without UME) eyes of 26 patients with uveitis and 19 eyes of 10 normal subjects. The procedure followed was fundus-related perimetry and retinal thickness map with an automated fundus perimetry/tomography system. Main outcome measures included quantification of macular sensitivity, fixation pattern, and relationship between macular sensitivity and thickness. RESULTS: Fixation stability revealed that 56 eyes (93.44%) had stable fixation (>75% within the central 2° of point of fixation); three eyes (6.56%) were relatively unstable (<75% of fixation points located within 2°, >75% located within 4°); and no eye had unstable fixation (<75% of fixation points located within 4°). Evaluation of fixation location revealed that 45 eyes (76.27%) had central fixation location (>50% of fixation point within 0.5 mm of foveal center); seven eyes (11.86%) had peri-central fixation location (25% << 50% within 0.5 mm); and seven eyes (11.86%) had eccentric (<25% of fixation point within 0.5 mm) fixation location. We measured macular sensitivity and corresponding thickness in 1,708 loci of 61 study eyes. Macular sensitivity increased by 0.02 dB (95% confidence interval, 0.00, 0.06) per 1 µm increase in the thickness for the thickness values ≤280 µm. Macular sensitivity decreased by 0.04 dB (95% CI, -0.08, -0.01) per 1 µm increase in the thickness for the thickness values >280 µm. CONCLUSIONS: Perimetry quantification of macular sensitivity and retinal thickness, in association with other factors, may offer novel information regarding the impact of UME on retinal function.

10.
Am J Ophthalmol ; 152(3): 400-405.e2, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21696702

RESUMEN

PURPOSE: To investigate relationship between macular sensitivity and retinal thickness in diabetic macular edema (DME). DESIGN: Prospective observational study. METHODS: settings: University-based retina practice. patients: Twenty-two eyes of 11 patients with DME. procedure: Fundus microperimetry and retinal thickness tomography were performed simultaneously using an automatic fundus perimetry/tomography system. main outcome measures: Quantification of macular sensitivity, fixation pattern, and relationship between macular sensitivity and retinal thickness. RESULTS: Fixation stability revealed that 21 eyes (95.4%) had stable fixation (>75% within central 2 degrees of point of fixation) and 1 eye (4.5%) had relatively unstable fixation (<75% of fixation points located within 2 degrees, >75% located within 4 degrees). Evaluation of fixation location revealed that 15 eyes (68.2%) had central (>50% of fixation points within 0.5 mm of fovea), 3 eyes (13.6%) pericentral (25% to 50% within 0.5 mm of fovea), and 4 eyes (18.2%) eccentric (<25% of fixation points within 0.5 mm of fovea) fixation location. Macular sensitivity increased by an average of 0.03 decibel (dB) (95% confidence interval [CI]: 0.00, 0.06) per 1-micron (µm) increase in retinal thickness for thickness values ≤280 µm measured with the OPKO/OTI spectral-domain OCT. The macular sensitivity decreased by an average 0.05 dB (95% CI: -0.08, -0.02) per 1-µm increase in thickness for thickness values >280 µm. CONCLUSIONS: In this pilot study, the majority of eyes with DME had stable, central fixation. Macular sensitivity varied depending on the thickness of the retina. Additional studies are needed to determine the role of microperimetry in eyes with DME.


Asunto(s)
Retinopatía Diabética/fisiopatología , Edema Macular/fisiopatología , Retina/patología , Agudeza Visual/fisiología , Campos Visuales/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Fijación Ocular/fisiología , Hemoglobina Glucada/análisis , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Estudios Prospectivos , Tomografía de Coherencia Óptica , Pruebas del Campo Visual
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA